BATON-CRC: a phase II randomized trial comparing tivozanib plus mFOLFOX6 with bevacizumab plus mFOLFOX6 in stage IV metastatic colorectal cancer

• Authors: BENSON Al.B.; KISS Igor; BRIDGEWATER John; ESKENS Ferry A.L.M.; SASSE Carolyn; VOSSEN Sandra; CHEN Jihong; CHIP Van Sant; HOWARD Howard; KEATING Anne; KRIVOSHIK Andrew
• Year of publication: 2016
• Type: Article in Periodical
• Magazine / Source: Journal of Experimental and Clinical Cancer Research
• Web: http://dx.doi.org/10.1158/1078-0432.CCR-15-3117
• Doi: http://dx.doi.org/10.1158/1078-0432.CCR-15-3117
• Keywords: Phase I-III trials; gastrointestinal cancers: colorectal; growth factor receptors and other surface molecules as targets for therapy